Mandate

Vinge advises Ampersand Capital Partners

April 22, 2016

Vinge advises Ampersand Capital Partners, a Boston based private equity firm, in connection with the forming of the Gyros Protein Technologies group. The new group consists of Ampersand’s portfolio company Protein Technologies, Inc., a US based provider of peptide synthesis instrumentation and reagents, and the Swedish Gyros group operating within automated nanoliter-scale immunoassays, who’s majority owner is the Swedish Sixth National Pension Fund.
 
Vinge’s team consisted of, among others, the partner in charge Christina Kokko and Kristina Ekberg, Oscar Rydén and Maria Schultzberg.

Vinge employs additional antitrust economists to further strengthen its practice

We welcome Adam Löfquist and Carl Widstrand to our EU, Competition & Regulatory practice group.
September 30, 2021

European Commission provides sanctions compliance guidance

The European Commission has recently issued three opinions regarding the interpretation of asset freeze provisions in certain sanctions legislation pertaining to Central African Republic, Ukraine, Libya and Syria. The opinions are also of relevance for other sanctions regimes which provide for the same or similar restrictions. Therefore, their practical relevance goes far beyond the sanctions regimes in the context of which they were issued and they therefore provide for helpful guidance regarding the required thresholds for sanctions compliance generally.
September 20, 2021

Vinge contributing to International Comparative Legal Guides

Vinge’s specialists within Maritime and Transport law have been requested to contribute with a chapter explaining the Swedish legislative framework in relation to maritime law in the International Comparative Legal Guides, ICLG.
August 20, 2021